Updated:
OSI Systems
OSI Systems was founded in 1987 by Deepak Chopra, who remains Chairman, President, and CEO.
OSI Systems
OSI Systems was founded in 1987 by Deepak Chopra, who remains Chairman, President, and CEO. The Hawthorne, California-headquartered company went public in 1997 and operates through three primary subsidiaries: Rapiscan Systems (security screening), Spacelabs Healthcare (patient monitoring and diagnostic cardiology), and Opto Electronics (optoelectronic components and subsystems). The firm generated over $1.3 billion in revenue for fiscal 2023, sourcing income from government security contracts, hospital networks, and industrial OEM customers. The company's largest segment, Rapiscan Systems, manufactures X-ray, gamma-ray, and trace detection systems used at airports, border crossings, cargo facilities, and critical infrastructure sites worldwide. Rapiscan deployments span North American TSA checkpoints, European Union airport hubs, and Middle Eastern logistics corridors. Spacelabs Healthcare supplies bedside monitors, anesthesia delivery systems, and telehealth platforms to hospitals and clinics, with a meaningful installed base in the United States and United Kingdom. The Opto Electronics division provides photodetectors, LED lighting components, and flex circuits to industrial and aerospace manufacturers, operating as a niche supplier rather than a branded platform. Chopra serves as the longest-tenured leader in the screening equipment sector, having guided OSI through multiple product cycles since aviation security became a federal priority after 2001. The company faced a meaningful regulatory event in 2014, reaching a settlement with the U.S. Department of Justice regarding Rapiscan's withdrawal of certain airport body scanners; Rapiscan refocused on cargo and checkpoint systems thereafter. OSI Systems repurchases shares opportunistically and uses selective acquisitions to fill Spacelabs product gaps, most recently acquiring a UK-based cardiology software firm in April 2024 (per the firm's disclosure, April 2024). OSI Systems' structural differentiator lies in operating three businesses with fundamentally different buyer profiles under one publicly traded parent — a security division selling to sovereign governments, a medical division selling to regulated hospitals, and a components division serving industrial OEMs. This portfolio architecture provides balance-of-cycle resilience uncommon among pure-play defense or medtech peers, though it also means the company competes on three separate operational fronts without the focus advantages of a specialist.
General information
Firm type
Asset Manager
Year founded
1987
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Hawthorne
Corporate office
Hawthorne, CA, United States
Principals
Deepak Chopra
Chairman, President & CEO
Sector focus
Frequently asked questions
Who runs investment decisions at OSI Systems?
Deepak Chopra, the founder, controls strategic capital allocation as Chairman, President, and CEO. OSI Systems is a public company, so major acquisitions and divestitures require board approval, but Chopra has set the investment direction for over three decades. The company does not operate a separate investment committee structure.
How does OSI Systems source its acquisition targets?
OSI Systems typically pursues small-to-midsize bolt-on acquisitions that fill product gaps in its Spacelabs Healthcare or Rapiscan Systems divisions. Targets are often privately held specialist firms — such as the UK-based cardiology software company acquired in April 2024 — that already have regulatory clearances and hospital relationships. The company does not participate in competitive auctions for large-scale platforms.
Is OSI Systems structured as a family office or does it operate more like a traditional public company?
OSI Systems is a publicly traded corporation listed on Nasdaq, not a family office. While founder Deepak Chopra retains significant influence and ownership, the company reports quarterly earnings, files 10-Ks with the SEC, and is subject to standard public-market governance requirements. Its structure is that of a traditional industrial conglomerate.
Does OSI Systems participate in fund commitments or only direct acquisitions?
OSI Systems does not operate as an investor making fund commitments. All capital deployment takes the form of direct acquisitions of operating companies or internal organic investment in its three business segments. The firm functions as an operator, not as a manager of third-party capital or LP stakes.
What investment stages does OSI Systems typically target?
Acquisition targets are mature, revenue-generating businesses with established regulatory approvals and customer relationships. OSI Systems does not invest in startups or venture-stage companies. Its medical acquisitions, for example, focus on firms with existing FDA or CE-marked products that can be sold through Spacelabs' existing distribution network.
How does OSI Systems' government contracting exposure affect its investment profile?
The Rapiscan Systems division derives a substantial portion of its revenue from U.S. and allied government agencies, creating a revenue base linked to public-sector budget cycles and geopolitical threat levels. This government exposure is balanced by Spacelabs' hospital-driven revenue and Opto Electronics' industrial OEM sales. The 2014 DOJ settlement over Rapiscan body scanners demonstrated that adverse regulatory outcomes can materially reshape segment focus.
Does OSI Systems maintain a venture arm or innovation fund separate from its operating businesses?
OSI Systems does not disclose a separate venture arm or innovation fund. Research and development is conducted within each operating division — Rapiscan, Spacelabs, and Opto Electronics — rather than through a consolidated corporate VC structure. The company's innovation model centers on internal engineering teams and targeted technology acquisitions.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: